Catalyst Wire Dossier Catalyst Wire Dossier

XELOX regimen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XELOX regimen, covering 2022-03-22 to 2023-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer [Phase 2]

See pricing